Trent J - Search Results

1

Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.

Blay JY, Shen L, Kang YK, Rutkowski P, Qin S, Nosov D, Wan D, Trent J, Srimuninnimit V, Pápai Z, Le Cesne A, Novick S, Taningco L, Mo S, Green S, Reichardt P, Demetri GD. Blay JY, et al. Among authors: trent j. Lancet Oncol. 2015 May;16(5):550-60. doi: 10.1016/S1470-2045(15)70105-1. Epub 2015 Apr 14. Lancet Oncol. 2015. PMID: 25882987 Free PMC article. Clinical Trial.

2

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.

Trent JC, Beach J, Burgess MA, Papadopolous N, Chen LL, Benjamin RS, Patel SR. Trent JC, et al. Cancer. 2003 Dec 15;98(12):2693-9. doi: 10.1002/cncr.11875. Cancer. 2003. PMID: 14669291 Free article. Clinical Trial.

3

Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

Scaife CL, Hunt KK, Patel SR, Benjamin RS, Burgess MA, Chen LL, Trent J, Raymond AK, Cormier JN, Pisters PW, Pollock RE, Feig BW. Scaife CL, et al. Among authors: trent j. Am J Surg. 2003 Dec;186(6):665-9. doi: 10.1016/j.amjsurg.2003.08.023. Am J Surg. 2003. PMID: 14672776

4

Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.

Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, Zhang W. Koh JS, et al. Among authors: trent j. Histol Histopathol. 2004 Apr;19(2):565-74. doi: 10.14670/HH-19.565. Histol Histopathol. 2004. PMID: 15024716 Review.

5

Update on the biology and therapy of gastrointestinal stromal tumors.

D'Amato G, Steinert DM, McAuliffe JC, Trent JC. D'Amato G, et al. Cancer Control. 2005 Jan-Feb;12(1):44-56. doi: 10.1177/107327480501200106. Cancer Control. 2005. PMID: 15668652 Free article. Review.

6

Imatinib mesylate in the treatment of gastrointestinal stromal tumour.

Steinert DM, McAuliffe JC, Trent JC. Steinert DM, et al. Expert Opin Pharmacother. 2005 Jan;6(1):105-13. doi: 10.1517/14656566.6.1.105. Expert Opin Pharmacother. 2005. PMID: 15709888 Review.

7

Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate.

Steinert DM, Oyarzo M, Wang X, Choi H, Thall PF, Medeiros LJ, Raymond AK, Benjamin RS, Zhang W, Trent JC. Steinert DM, et al. Cancer. 2006 Apr 1;106(7):1617-23. doi: 10.1002/cncr.21781. Cancer. 2006. PMID: 16518826 Free article.

8

New developments in gastrointestinal stromal tumor.

Trent JC, Benjamin RS. Trent JC, et al. Curr Opin Oncol. 2006 Jul;18(4):386-95. doi: 10.1097/01.cco.0000228747.02660.e2. Curr Opin Oncol. 2006. PMID: 16721136 Review.

9

Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.

Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Andtbacka RH, et al. Among authors: trent j. Ann Surg Oncol. 2007 Jan;14(1):14-24. doi: 10.1245/s10434-006-9034-8. Ann Surg Oncol. 2007. PMID: 17072676

10

Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor.

Kleinbaum EP, Lazar AJ, Tamborini E, Mcauliffe JC, Sylvestre PB, Sunnenberg TD, Strong L, Chen LL, Choi H, Benjamin RS, Zhang W, Trent JC. Kleinbaum EP, et al. Among authors: trent jc. Int J Cancer. 2008 Feb 1;122(3):711-8. doi: 10.1002/ijc.23137. Int J Cancer. 2008. PMID: 17943734 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

964 results

Search Page